Matsumoto Yushi-Seiyaku Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History 1Years Growth
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥450 | +12.5% |
| 2025 | ¥400 | 0.0% |
| 2024 | ¥400 | +14.3% |
| 2023 | ¥350 | 0.0% |
| 2022 | ¥350 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥39,627M | ¥41,526M | ¥43,131M | ¥41,069M |
| Gross Profit | ¥12,015M | ¥12,957M | ¥13,690M | ¥12,393M |
| Operating Income | ¥7,778M | ¥8,758M | ¥9,282M | ¥8,161M |
| Pretax Income | ¥10,044M | ¥10,747M | ¥9,740M | ¥11,442M |
| Net Income | ¥7,247M | ¥7,504M | ¥6,830M | ¥8,037M |
| EPS | ¥2,259.37 | ¥2,586.38 | ¥2,354.19 | ¥2,770.53 |
| Operating Margin | 19.63% | 21.09% | 21.52% | 19.87% |
| Balance Sheet | ||||
| Total Assets | ¥79,190M | ¥89,512M | ¥95,189M | ¥105,916M |
| Total Equity | ¥64,693M | ¥73,357M | ¥79,402M | ¥89,229M |
| Total Liabilities | ¥14,497M | ¥16,155M | ¥15,787M | ¥16,687M |
| Cash | ¥25,882M | ¥29,993M | ¥32,037M | ¥33,331M |
| Interest-bearing Debt | - | - | - | - |
| Equity Ratio | 81.69% | 81.95% | 83.42% | 84.25% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥5,419M | ¥7,374M | ¥7,767M | ¥6,658M |
| Investing CF | ¥144M | -¥17,870M | -¥9,055M | -¥5,350M |
| Financing CF | -¥5,933M | -¥1,020M | -¥1,242M | -¥1,168M |
| Free CF | ¥4,982M | ¥6,310M | ¥6,585M | ¥6,277M |
| Efficiency | ||||
| ROE | 11.20% | 10.23% | 8.60% | 9.01% |
| ROA | 9.15% | 8.38% | 7.18% | 7.59% |
Latest IR Information
-
Matsumoto Abies Pharmaceutical Co., Ltd. (4365) FY2027 March Quarter 1 Financial Summary
Net sales of 11,135 million yen (YoY +6.1%), operating income of 2,270 million yen (YoY +12.1%), net income attributable to owners of parent of 2,004 million yen. Segments include Japan and Asia, and due to resource reallocation and demand recovery,...
Read more -
Matsumoto Yushi Seiyaku Co., Ltd. "Notice Regarding Full-Year Forecast for the Fiscal Year Ending March 2027 and Dividend Forecast"
The full-year consolidated earnings forecast for the fiscal year ending March 2027 was previously undecided, but at this point the full-year earnings forecast is disclosed. Dividend forecast is 450 yen per share, with potential for revision depending on future economic...
Read more -
【Matsumoto Yushi Seiyaku】2026 June Term Parent Company and Controlling Shareholder Information｜June 2026
Matsumoto Yushi Seiyaku has exchanged personnel and management information with its parent company, Matsumoto Kōsan Co., Ltd., holding 23.57% of voting rights. There will be no changes in this relationship moving forward, and no business transactions are conducted.
Read more -
【Matsumoto Oil & Fat Pharmaceutical】2026 Financial Results | Revenue approximately 590 million yen / Net profit approximately 1.92 million yen
Matsumoto Oil & Fat Pharmaceutical's FY2026 financial results show revenue of approximately 590 million yen and net profit of approximately 1.92 million yen. Share buyback and shareholder composition are also disclosed.
Read more -
[Matsumoto Yushi Seiyaku] Announces Executive Changes | June 25, 2026
Matsumoto Yushi Seiyaku has announced plans to implement executive personnel changes on June 25, 2026. A partial correction regarding the change of the statutory auditors has also been made, and the final decision will be made after the shareholders' meeting.
Read more
Latest News (5 items)
Company Information
About
Matsumoto Yushi-Seiyaku Co., Ltd. produces and supplies surface active agents and polymers in Japan, China, Taiwan, Asia, and internationally. It offers spin finishes for extrusion spinning, textile spinning, and functional surface treatment of fibers; sizing chemicals for weaving; knitting and weaving lubricants; scouring agents and detergents; and dyeing and processing auxiliaries, including moisture management, antistatic, water-repellent finishing, anti-soiling, flame-retardants, and anti-light-fastness agents. The company also provides thermo-expandable microcapsules; microbeads; three-dimensional copying systems; anti-tack powder for batch off and inner parting lubricants for bladder-tire parting; modifiers, antistatic agents, anti-fogging agents, and lubricants for plastic materials; emulsifiers, base materials for shampoo and body soaps, fragrance and oil solubilizing agents, and pearl forming agents; chemicals for civil engineering and construction; and chemicals for environment conservation. Its products are used in information and electronics, automobile, precision instruments, civil engineering, construction, rubber, plastics, cosmetics, toiletries, and agriculture industries. The company was founded in 1926 and is headquartered in Yao, Japan.
